US Patent Issued to FACULDADES CATOLICAS on April 14 for "N-acylhydrazonic compounds, use in the treatment of amyloid and non-amyloid degenerative aggregopathies, and pharmaceutical composition" (Brazilian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,701, issued on April 14, was assigned to FACULDADES CATOLICAS (Rio de Janeiro, Brazil).

"N-acylhydrazonic compounds, use in the treatment of amyloid and non-amyloid degenerative aggregopathies, and pharmaceutical composition" was invented by Nicolas Adrian Rey (Rio de Janeiro, Brazil) and Daphne Schneider Cukierman Rey (Rio de Janeiro, Brazil).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a family of N-acylhydrazonic compounds structurally derived from 1-methyl-1H-imidazole-2-carboxaldehyde, or pharmaceutically acceptable salts thereof, and the use of said compounds to prevent and/or treat amyloid (such as Alzheimer...